COPD

COPD

Emphysema Treatment Market 2024 by Keyplayers and Vendors: Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, Em – IndiaPolitics.com

The emphysema treatment market has witnessed significant growth in recent years, driven by advancements in medical technology and a rising focus on symptom management. Key players such as Pulmonx, Bioxyne, Intrexon, Icure Pharmaceuticals, Kamada, and Emphasys Medical are leading the charge in developing innovative treatments to combat this debilitating respiratory condition..

COPD

ResMed Aiming to Reach 500 Million Breathing Health Patients by 2030

In a significant move aimed at transforming the sleep health and breathing health landscape, ResMed Inc. (NYSE: RMD) has unveiled its ambitious 2030 strategy..